Security record · archived quarter
RNAM
Avidity Biosciences Inc · Healthcare · Biotechnology
11Tracked holders
0Δ holders
25.98MShares held
$1.19BReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +17.4% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.63M | -2.6% | $488.42M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ ×8 |
| 3 | Adage Capital Partners ✦ | 3.08M | -9.3% | $141.44M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.59M | +14.6% | $118.77M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 1.11M | +50.0% | $50.92M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passive) | 1.05M | New | $48.08M | 0.0% | New | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 182.21K | +63.0% | $8.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 141.90K | -62.4% | $6.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 130.09K | -42.4% | $5.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 24.95K | +107.2% | $1.15M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 11 | Millennium Management ✦ | 18.54K | -85.2% | $851,358 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Norges Bank | $48.08M | 0.0% |
Exited
| Citadel Advisors | $6.57M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 8.00K shares, $236,160 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API